Stoke Therapeutics Inc’s filing revealed that its 10% Owner Skorpios Trust unloaded Company’s shares for reported $23.0 million on Dec 23 ’24. In the deal valued at $11.50 per share,2,000,000 shares were sold. As a result of this transaction, Skorpios Trust now holds 6,906,181 shares worth roughly $70.93 million.
Then, Blue Horizon Enterprise Ltd bought 2,000,000 shares, generating $23,180,000 in total proceeds.
Before that, Ticho Barry sold 2,586 shares. Stoke Therapeutics Inc shares valued at $33,596 were divested by the CHIEF MEDICAL OFFICER at a price of $12.99 per share. As a result of the transaction, Ticho Barry now holds 44,746 shares, worth roughly $0.46 million.
Chardan Capital Markets initiated its Stoke Therapeutics Inc [STOK] rating to a Buy in a research note published on December 20, 2024; the price target was $24. TD Cowen also remained covering STOK and has increased its forecast on March 26, 2024 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of STOK
On Monday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock fall -9.52% to $10.27. Over the last five days, the stock has lost -10.85%. Stoke Therapeutics Inc shares have fallen nearly -6.89% since the year began. Nevertheless, the stocks have risen 136.64% over the past one year. While a 52-week high of $17.58 was reached on 02/05/25, a 52-week low of $4.09 was recorded on 01/14/25. SMA at 50 days reached $11.21, while 200 days put it at $13.02.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 9.68, which if violated will result in even more drops to 9.09. On the upside, there is a resistance level at 11.16. A further resistance level may holdings at 12.05. The Relative Strength Index (RSI) on the 14-day chart is 44.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.63%. Stochastics %K at 55.85% indicates the stock is a holding.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2025-01-15, growing by 1.5 million shares to a total of 8.75 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 7.26 million shares. There was a rise of 17.1%, which implies that there is a positive sentiment for the stock.
